Home >> Signaling Pathways >> Apoptosis

Apoptosis

As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.

Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.

Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.

Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.

Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.

Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.

One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.

p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.

Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9). 

Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.

References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.

What is Apoptosis? The Apoptotic Pathways and the Caspase Cascade

Targets for  Apoptosis

Products for  Apoptosis

  1. Cat.No. Product Name Information
  2. GC38182 Dauricine Dauricine  Chemical Structure
  3. GC49913 Davunetide (acetate) A neuroprotective ADNP-derived peptide Davunetide (acetate)  Chemical Structure
  4. GC63364 DB2115 tertahydrochloride 2-Deoxy-2-fluoro-L-fucose, an L-fucose analog, is a fucosylation inhibitor. 2-Deoxy-2-fluoro-L-fucose inhibits de novo synthesis of GDP-fucose in mammalian cells. Fucosylation is a relatively well-defined biomarker for progression in many human cancers; for example, pancreatic and hepatocellular carcinoma. DB2115 tertahydrochloride  Chemical Structure
  5. GC62222 DB2313 DB2313 is a potent transcription factor PU.1 inhibitor with an apoptosis of 14 nM. DB2313 disrupts the interaction of PU.1 with target gene promoters. DB2313 induces apoptosis of acute myeloid leukemia (AML) cells, and has anticancer effects. DB2313  Chemical Structure
  6. GC10824 DBeQ P97 ATPase inhibitor DBeQ  Chemical Structure
  7. GC32719 dBET6 dBET6 is a highly potent, selective and cell-permeable PROTAC connected by ligands for Cereblon and BET, with an IC50 of 14 nM, and has antitumor activity. dBET6  Chemical Structure
  8. GC19485 DC661

    A potent PPT1 inhibitor

    DC661   Chemical Structure
  9. GC16795 DCA DCA is a metabolic regulator in cancer cells' mitochondria with anticancer activity. DCA inhibits PDHK, resulting in decreased lactic acid in the tumor microenvironment. DCA increases reactive oxygen species (ROS) generation and promotes cancer cell apoptosis. DCA also works as NKCC inhibitor. DCA  Chemical Structure
  10. GC14007 DCC-2036 (Rebastinib) DCC-2036 (Rebastinib) (DCC-2036) is an orally active, non-ATP-competitiveBcr-Abl inhibitor for Abl1WT and Abl1T315I with IC50s of 0.8 nM and 4 nM, respectively. DCC-2036 (Rebastinib) also inhibits SRC, KDR, FLT3, and Tie-2, and has low activity to seen towards c-Kit. DCC-2036 (Rebastinib)  Chemical Structure
  11. GC33934 DCVC DCVC (S-[(1E)-1,2-dichloroethenyl]--L-cysteine) is a bioactive metabolite of trichloroethylene (TCE). DCVC  Chemical Structure
  12. GC64971 DDO-7263 DDO-7263, a 1,2,4-Oxadiazole derivative, is a potent Nrf2-ARE activator. DDO-7263  Chemical Structure
  13. GC52191 Deacetylanisomycin Deacetylanisomycin is a potent growth regulator in plants and an inactive derivative of Anisomycin. Deacetylanisomycin  Chemical Structure
  14. GC15255 Decitabine(NSC127716, 5AZA-CdR) Decitabine(DAC) is a deoxycytidine analogue antimetabolite with oral bioactivity and functions as an inhibitor of DNA methyltransferase. Decitabine(NSC127716, 5AZA-CdR)  Chemical Structure
  15. GC31892 Decursin ((+)-Decursin) Decursin ((+)-Decursin) ((+)-Decursin ((+)-Decursin)) is a potent anti-tumor agent. Decursin ((+)-Decursin)  Chemical Structure
  16. GC18556 Degarelix (acetate) Degarelix is a synthetic gonadotropin-releasing hormone receptor (GNRHR) antagonist (IC50 = 3 nM in HEK293 cells expressing the human receptor). Degarelix (acetate)  Chemical Structure
  17. GC15484 Deguelin A potent antiproliferative rotenoid compound Deguelin  Chemical Structure
  18. GC35829 Dehydroaltenusin Dehydroaltenusin is a small molecule selective inhibitor of eukaryotic DNA polymerase α, a type of antibiotic produced by a fungus with an IC50 value of 0.68 μM. The inhibitory mode of action of dehydroaltenusin against mammalian pol α activity is competitive with respect to the DNA template primer (Ki=0.23 ?M) and non-competitive with respect to the 2'-deoxyribonucleoside 5'-triphosphate substrate (Ki=0.18 ?M). Dehydroaltenusin arrests the cancer cell cycle at the S-phase and triggers apoptosis. Dehydroaltenusin possesses anti-tumor activity against human adenocarcinoma tumor in vivo. Dehydroaltenusin  Chemical Structure
  19. GN10040 Dehydrocorydaline Dehydrocorydaline  Chemical Structure
  20. GC35834 Dehydroeffusol Dehydroeffusol is a phenanthrene from medicinal herb Juncus effuses. Dehydroeffusol inhibits gastric cancer cell growth and tumorigenicity by selectively inducing tumor-suppressive endoplasmic reticulum stress and a moderate apoptosis. It shows very low toxicity. Dehydroeffusol  Chemical Structure
  21. GC38452 Dehydrotrametenolic acid Dehydrotrametenolic acid is a sterol isolated from the sclerotium of Poria cocos. Dehydrotrametenolic acid  Chemical Structure
  22. GC16214 DEL-22379 inhibitor of the dimerization of ERK DEL-22379  Chemical Structure
  23. GC43406 Delphinidin (chloride)

    Delphinidin (chloride) is an anthocyanidin, a natural plant pigment which serves as the precursor of certain anthocyanins that provide the blue-red colors of flowers, fruits, and red wine.

    Delphinidin (chloride)  Chemical Structure
  24. GN10529 Demethoxycurcumin Demethoxycurcumin  Chemical Structure
  25. GC38160 Demethylzeylasteral A nortriterpenoid with diverse biological activities Demethylzeylasteral  Chemical Structure
  26. GC43408 Deoxycholic Acid (sodium salt hydrate) Deoxycholic acid (cholanoic acid) sodium hydrate,a bile acid, is a by-product of intestinal metabolism, that activates the G protein-coupled bile acid receptorTGR5. Deoxycholic Acid (sodium salt hydrate)  Chemical Structure
  27. GC47187 Deoxycholic Acid-d4 A quantitative analytical standard guaranteed to meet MaxSpec® identity, purity, stability, and concentration specifications Deoxycholic Acid-d4  Chemical Structure
  28. GC68306 Deoxynyboquinone Deoxynyboquinone  Chemical Structure
  29. GC38564 Deoxypodophyllotoxin Deoxypodophyllotoxin (DPT), a derivative of podophyllotoxin, is a lignan with potent antimitotic, anti-inflammatory and antiviral properties isolated from rhizomes of Sinopodophullumhexandrum (Berberidaceae). Deoxypodophyllotoxin  Chemical Structure
  30. GC16077 Deracoxib Selective COX-2 inhibitor Deracoxib  Chemical Structure
  31. GC34157 Desacetylcinobufotalin (Deacetylcinobufotalin) Desacetylcinobufotalin (Deacetylcinobufotalin) is a natural compound; apoptosis inducer and shows the marked inhibition effect to HepG2 cells and the IC50 value is 0.0279μmol/ml. Desacetylcinobufotalin (Deacetylcinobufotalin)  Chemical Structure
  32. GC62927 Desmethylxanthohumol Desmethylxanthohumol is a prenylated hydroxychalcone isolated from hop cones (Humulus lupulus L.). Desmethylxanthohumol is a powerful apoptosis inducing agent. Desmethylxanthohumol has antiplasmodial, antiproliferative, and antioxidant bioactivities. Desmethylxanthohumol  Chemical Structure
  33. GC38221 Desoxyrhaponticin Desoxyrhaponticin is a stilbene glycoside from the Tibetan nutritional food Rheum tanguticum Maxim. Desoxyrhaponticin is a Fatty acid synthase (FASN) inhibitor, and has apoptotic effect on human cancer cells. Desoxyrhaponticin  Chemical Structure
  34. GC10661 Destruxin B insecticidal and phytotoxic activity;induces apoptosis Destruxin B  Chemical Structure
  35. GC10520 Dextran sulfate sodium salt (M.W 200000) Dextran sulfate sodium salt is a is a polymer of anhydroglucose with the molecular weight range of 35000-45000. Dextran sulfate sodium salt (M.W 200000)  Chemical Structure
  36. GC38250 Dextran sulfate sodium salt (MW 16000-24000) A sulfated polysaccharide Dextran sulfate sodium salt (MW 16000-24000)  Chemical Structure
  37. GC38252 Dextran sulfate sodium salt (MW 35000-45000) A sulfated polysaccharide Dextran sulfate sodium salt (MW 35000-45000)  Chemical Structure
  38. GC38253 Dextran sulfate sodium salt (MW 4500-5500) A sulfated polysaccharide Dextran sulfate sodium salt (MW 4500-5500)  Chemical Structure
  39. GC38251 Dextran sulfate sodium salt (MW 450000-550000) A sulfated polysaccharide Dextran sulfate sodium salt (MW 450000-550000)  Chemical Structure
  40. GC43436 Diacetylcercosporin Diacetylcercosporin is a perylenequinone produced by Cercospora and Septoria that has diverse biological activities. Diacetylcercosporin  Chemical Structure
  41. GC45992 Diallyl Tetrasulfide An organosulfur compound with diverse biological activities Diallyl Tetrasulfide  Chemical Structure
  42. GC43439 Diallyl Trisulfide Hydrogen sulfide (H2S) is an endogenously-produced gaseous second messenger that can regulate many physiological processes. Diallyl Trisulfide  Chemical Structure
  43. GC35859 Diazepinomicin Diazepinomicin (TLN-4601) is a secondary metabolite produced by Micromonospora sp. Diazepinomicin (TLN-4601) inhibits the EGF-induced Ras-ERK MAPK signaling pathway and induces apoptosis. An anti-tumor agent for K-Ras mutant models. Diazepinomicin  Chemical Structure
  44. GC61419 Dibenzoylmethane Dibenzoylmethane, a minor ingredient in licorice, activates Nrf2 and prevents various cancers and oxidative damage. Dibenzoylmethane  Chemical Structure
  45. GC64139 Dibromoacetic acid Dibromoacetic acid  Chemical Structure
  46. GC14622 Diclofenac Potassium nonsteroidal anti-inflammatory drug Diclofenac Potassium  Chemical Structure
  47. GN10751 Dictamnine Dictamnine  Chemical Structure
  48. GC49153 Didemnin B Didemnin B is a cyclic depsipeptide produced by marine tunicates that specifically binds the GTP-bound conformation of EEF1A. Didemnin B  Chemical Structure
  49. GC39808 Didesmethylrocaglamide Didesmethylrocaglamide, a derivative of Rocaglamide, is a potent eukaryotic initiation factor 4A (eIF4A) inhibitor. Didesmethylrocaglamide has potent growth-inhibitory activity with an IC50 of 5 nM. Didesmethylrocaglamide suppresses multiple growth-promoting signaling pathways and induces apoptosis in tumor cells. Antitumor activity. Didesmethylrocaglamide  Chemical Structure
  50. GC38179 Didymin A flavonoid with diverse biological activities Didymin  Chemical Structure
  51. GC15578 Dienogest Orally active synthetic progesterone Dienogest  Chemical Structure
  52. GC43452 Diffractaic Acid Diffractaic acid is a lichen metabolite that has been found in P. Diffractaic Acid  Chemical Structure
  53. GC64375 Difopein TFA Difopein (TFA), a specific and competitive inhibitor of 14-3-3 protein (a highly conserved eukaryotic regulatory molecule), blocking the ability of 14-3-3 to bind to target proteins and inhibits 14-3-3/Ligand interactions. Difopein (TFA) leads to induction of apoptosis and enhances the ability of cisplatin to kill cells. Difopein TFA  Chemical Structure
  54. GC49842 Digoxigenin Bisdigitoxoside A Na+/K+-ATPase inhibitor Digoxigenin Bisdigitoxoside  Chemical Structure
  55. GN10056 Dihydroartemisinin Dihydroartemisinin  Chemical Structure
  56. GC38617 Dihydrokaempferol A flavone with diverse biological activities Dihydrokaempferol  Chemical Structure
  57. GC43462 Dihydrolipoic Acid Dihydrolipoic acid (DHLA) is a dithiol-containing carboxylic acid that is the reduced form of α-lipoic acid. Dihydrolipoic Acid  Chemical Structure
  58. GC38620 Dihydrorotenone Dihydrorotenone, a natural pesticide, is a potent mitochondrial inhibitor. Dihydrorotenone  Chemical Structure
  59. GC41112 Dihydroxy Melphalan Dihydroxy melphalan is an inactive degradation product of melphalan. Dihydroxy Melphalan  Chemical Structure
  60. GC43463 DiIC1(5) DiIC1(5) is a signal-off fluorescent probe for the detection of mitochondrial membrane potential disruption. DiIC1(5)  Chemical Structure
  61. GC38772 DIM-C-pPhOH A Nur77 antagonist DIM-C-pPhOH  Chemical Structure
  62. GC16590 Dimethyl Fumarate nuclear factor (erythroid-derived)-like 2 (Nrf2) pathway activator Dimethyl Fumarate  Chemical Structure
  63. GC62936 Dimethyl fumarate D6 Dimethyl fumarate D6 is a deuterium labeled Dimethyl fumarate. Dimethyl fumarate D6  Chemical Structure
  64. GC25351 Dimethyl itaconate Dimethyl itaconate can reprogram neurotoxic to neuroprotective primary astrocytes through the regulation of LPS-induced Nod-like receptor protein 3 (NLRP3) inflammasome and nuclear factor 2/heme oxygenase-1 (NRF2/HO-1) pathways. Dimethyl itaconate  Chemical Structure
  65. GN10531 Dimethylfraxetin Dimethylfraxetin  Chemical Structure
  66. GC17648 Dinaciclib(SCH727965) Dinaciclib(SCH727965) (SCH 727965) is a potent inhibitor of CDK, with IC50s of 1 nM, 1 nM, 3 nM, and 4 nM for CDK2, CDK5, CDK1, and CDK9, respectively. Dinaciclib(SCH727965)  Chemical Structure
  67. GN10284 Dioscin Dioscin  Chemical Structure
  68. GC38408 Diosgenin glucoside Diosgenin glucoside  Chemical Structure
  69. GC60782 Disitertide TFA Disitertide (P144) TFA is a peptidic transforming growth factor-beta 1 (TGF-β1) inhibitor specifically designed to block the interaction with its receptor. Disitertide (P144) TFA is also a PI3K inhibitor and an apoptosis inducer. Disitertide TFA  Chemical Structure
  70. GC10801 Disulfiram An irreversible inhibitor of aldehyde dehydrogenase Disulfiram  Chemical Structure
  71. GC39295 DJ001 DJ001 is a highly specific, selective and non-competitive protein tyrosine phosphatase-σ (PTPσ) inhibitor with an IC50 of 1.43 μM. DJ001  Chemical Structure
  72. GC49164 DM4 (hydrate) A derivative of maytansine DM4 (hydrate)  Chemical Structure
  73. GC35882 dMCL1-2 dMCL1-2 is a potent and selective PROTAC of myeloid cell leukemia 1 (MCL1) (Bcl-2 family member) based on Cereblon, which binds to MCL1 with a KD of 30 nM. dMCL1-2 activats the cellular apoptosis machinery by degradation of MCL1. dMCL1-2  Chemical Structure
  74. GC40192 DMPAC-Chol DMPAC-Chol is a cationic cholesterol derivative that has been used in liposome formation for gene transfection. DMPAC-Chol  Chemical Structure
  75. GC61466 DMU-212 DMU-212 is a methylated derivative of Resveratrol, with antimitotic, anti-proliferative, antioxidant and apoptosis promoting activities. DMU-212 induces mitotic arrest via induction of apoptosis and activation of ERK1/2 protein. DMU-212 has orally active. DMU-212  Chemical Structure
  76. GC16684 Docetaxel

    Docetaxel is a taxane class of anti-mitotic chemotherapeutic agents with an IC50 of 0.2 µM.

    Docetaxel  Chemical Structure
  77. GA21397 Dolastatin 15 Dolastatin 15 originally isolated from the sea hare Dolabella auricularia belongs to a family of antimitotic and antineoplastic depsipeptides inducing apoptosis in various malignant cell types. It was shown to inhibit the growth of the P388 lymphocytic leukemia cell line efficiently, with an ED?? value of 2.4 ng/mL. Dolastatin 15  Chemical Structure
  78. GC11099 Doxifluridine oral prodrug of the antineoplastic agent 5-fluorouracil (5-FU) Doxifluridine  Chemical Structure
  79. GC18439 Doxorubicinone A metabolite of doxorubicin Doxorubicinone  Chemical Structure
  80. GC15399 Dp44mT iron chelator and anticancer agent Dp44mT  Chemical Structure
  81. GC33384 DPBQ DPBQ activates p53 and triggers apoptosis in a polyploid-specific manner, but does not inhibit topoisomerase or bind DNA. DPBQ elicits expression and phosphorylation of p53 and this effect is specific to tetraploid cells. DPBQ  Chemical Structure
  82. GC35898 Dracorhodin perchlorate A pro-apoptotic compound Dracorhodin perchlorate  Chemical Structure
  83. GC39707 Droloxifene A selective estrogen receptor modulator Droloxifene  Chemical Structure
  84. GC13706 Droxinostat An inhibitor of HDAC3, HDAC6, and HDAC8 Droxinostat  Chemical Structure
  85. GC35908 Duocarmycin A Duocarmycin A, which is one of well-known antitumor antibiotics, is a DNA alkylator and efficiently alkylates adenine N3 at the 3′ end of AT-rich sequences in the DNA. Duocarmycin A, as a chemotherapeutic agent, results HLC-2 cells typically apoptotic changes, including chromatin condensation, sub-G1 accumulation in DNA histogram pattern, and decrease in procaspase-3 and 9 levels. Duocarmycin A  Chemical Structure
  86. GC35913 Durvalumab

    A humanized anti-PD-L1 monoclonal antibody

    Durvalumab  Chemical Structure
  87. GC10893 Dutasteride 5-alpha-reductase inhibitor Dutasteride  Chemical Structure
  88. GC62590 E64FC26 E64FC26 is a potent pan-inhibitor of the protein disulfide isomerase (PDI) family, with IC50s of 1.9, 20.9, 25.9, 16.3, and 25.4 μM against PDIA1, PDIA3, PDIA4, TXNDC5, and PDIA6, respectively. E64FC26 shows anti-myeloma activity. E64FC26  Chemical Structure
  89. GC39377 EB-3D EB-3D is a potent and selective choline kinase α (ChoKα) inhibitor, with an IC50 of 1 μM for ChoKα1. EB-3D exerts effects on ChoKα expression, AMPK activation, apoptosis, endoplasmic reticulum stress and lipid metabolism. EB-3D exhibits a potent antiproliferative activity in a panel of T-leukemia cell lines. Anti-cancer activity. EB-3D  Chemical Structure
  90. GC50282 EC 19 Synthetic retinoid; induces differentiation of stem cells EC 19  Chemical Structure
  91. GC39174 EC359 EC359 is a potent, selective, high affinity and orally active leukemia inhibitory factor receptor (LIFR) inhibitor with a Kd of 10.2 nM, which directly interacts with LIFR to effectively block LIF/LIFR interactions. EC359  Chemical Structure
  92. GC38149 Ecabet sodium An antiulcerative and gastroprotective agent Ecabet sodium  Chemical Structure
  93. GN10504 Echinocystic acid Echinocystic acid  Chemical Structure
  94. GC47279 Echinosporin A bacterial metabolite with antibacterial and anticancer activities Echinosporin  Chemical Structure
  95. GC63871 Echitamine chloride Echitamine chloride is the major monoterpene indole alkaloid present in Alstonia with potent anti-tumour activity. Echitamine chloride induces DNA fragmentation and cells apoptosis. Echitamine chloride inhibits pancreatic lipase with an IC50 of 10.92 μM. Echitamine chloride  Chemical Structure
  96. GC63470 Eclitasertib Eclitasertib (DNL-758) is a potent receptor-interacting protein kinase 1 (RIPK1) inhibitor with an IC50 of <1 ?Μ (From patent WO2017136727A2, example 42). Eclitasertib  Chemical Structure
  97. GC33156 Ecteinascidin 770 (Ecteinascidine 770) Ecteinascidin 770 (Ecteinascidine 770) (ET-770) is a 1,2,3,4-tetrahydroisoquinoline alkaloid with potent anti-cancer activities; inhibits U373MG cells with an IC50 of 4.83 nM. Ecteinascidin 770 (Ecteinascidine 770)  Chemical Structure
  98. GC12838 Edaravone A radical scavenger and antioxidant Edaravone  Chemical Structure
  99. GC62562 EGFR-IN-11 EGFR-IN-11 is a fourth-generation EGFR-tyrosine kinase inhibitor (EGFR-TKI) with an IC50 of 18 nM for triple mutant EGFRL858R/T790M/C797S. EGFR-IN-11 significantly suppresses the EGFR phosphorylation, induce the apoptosis, and arrest cell cycle at G0/G1. EGFR-IN-11  Chemical Structure
  100. GC14756 EI1 EZH2 inhibitor EI1  Chemical Structure
  101. GC64864 EJMC-1 EJMC-1 is a moderately potent TNF-α inhibitor with an IC50 value of 42 μM. EJMC-1  Chemical Structure

Items 701 to 800 of 2214 total

per page
  1. 6
  2. 7
  3. 8
  4. 9
  5. 10

Set Descending Direction